A dual-process of targeted and unbiased Nanopore sequencing enables accurate and rapid diagnosis of lower respiratory infections.

Authors:
Guo Y; Li Z; Li L; Li S; Sun L and 19 more

Journal:
EBioMedicine

Publication Year: 2023

DOI:
10.1016/j.ebiom.2023.104858

PMCID:
PMC10652131

PMID:
37925777

Journal Information

Full Title: EBioMedicine

Abbreviation: EBioMedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"metagenomic sequencing data with human genome removed were deposited as national center for biotechnology information (ncbi) sequence read archive (sra) under bioproject prjna818777."

Code Sharing
Evidence found in paper:

"Declaration of interests Yifan Guo, Lijuan Li, Lingxiao Sun, Yuyao Yin, Shijun Sun, Binghuai Lu, Jiajing Han, Kang Chang, Li Gu, Chendi Jing, Hongbin Chen, and Hui Wang declare that they have no conflict of interest. Zhenzhong Li, Shan Li, Xinfang Yang, Yan Dai, Ju Gu, Lan Yang, Xue Liu, Manjiao Liu, Hui Xu, Ryon Liu, Yong Ren and Hao Guo are affiliated with Simcere Diagnostics Co., Ltd and Nanjing Simcere Medical Laboratory Science Co., Ltd."

Evidence found in paper:

"This study was supported by the 10.13039/501100012166National Key Research and Development Program of China (grant number 2018YFE0102100) and 10.13039/501100001809National Natural Science Foundation of China (grant number 81625014)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025